CCL2 and chronic kidney disease: Similar results were obtained in a hospitalized cohort of 1,538 older patients, where high urinary MCP-1 and YKL-40 concentrations were associated with eGFR decline, CKD progression and all-cause mortality, over a median follow-up time of 4.3 years (125).